Peter J. Campbell
0000-0002-3921-0510
Publication & Citation Trends
Publications
0 total
Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease OA
Cited by 59
Semantic Scholar
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones OA
Cited by 8
Semantic Scholar
Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease OA
Cited by 0
Semantic Scholar
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates OA
Cited by 15
Semantic Scholar
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer. OA
Cited by 67
Semantic Scholar
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression OA
Cited by 59
Semantic Scholar
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis OA
Cited by 62
Semantic Scholar
Clonal Dynamics of Normal Haematopoiesis with Human Ageing OA
Cited by 1
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(278)
Acute Myeloid Leukemia Research
(90)
Myeloproliferative Neoplasms: Diagnosis and Treatment
(88)
Genetic factors in colorectal cancer
(64)
Chronic Myeloid Leukemia Treatments
(49)
Affiliations
Airbus (Italy)
AstraZeneca (United Kingdom)
Courtauld Institute of Art
Autism Speaks
University of Bern